Israeli health ministry, Government ministry

Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers."We are proud to announce, that Japan has approved COVAXIN booster dose for travellers. Another global recognition of the effectiveness of our universal COVID vaccine," Bharat Biotech tweeted.Quarantine Station of Japan's Ministry of Health, Labour and Welfare issued an advisory for the Quarantine period after entering Japan.In an official statement, the ministry said, "Travelers who are entering or returning to Japan from countries/regions categorized as "RED" in border control measures(28) and who have not had three doses of a COVID-19 vaccination will be required to quarantine for three days at accommodations designated by a quarantine station."It further said that the travellers will not be required to quarantine after leaving the facility. if the results of a test taken at the accommodations are negative."Travelers who are entering or returning to Japan from countries/regions categorized as "RED" in border control measures(28) and who have a certificate confirming they have received three vaccination doses will be required to quarantine at home/accommodations of their choosing for five days, in principle.""However, if they take a self-test after three days after entering Japan and submit a negative result to the Ministry of Health, Labour and Welfare (Health Monitoring Center for Overseas Entrants, or HCO) where its status is confirmed, they will not be required to remain in quarantine after that," the statement added.The statement also said that "Travelers who are entering or returning to Japan from countries/regions categorized as "YELLOW" in border control measures(28) and have not received three vaccination doses will be required to quarantine at home/accommodations of their choosing for five days, in principle.""However, if they take a self-test after three days after entering Japan and submit a negative result to the Ministry of Health, Labour and Welfare (Health Monitoring Center for Overseas Entrants, or HCO) where its status is confirmed, they will not be required to remain in quarantine after that," it added.According to Bharat Biotech, Covaxin is formulated uniquely such that the same dosage can be administered to adults and children alike, for primary and booster doses, making it a universal vaccine.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Israeli Health MinistryFOLLOW

Israeli health ministry, Latest News

Kampala, Oct 3 At least 65 health workers in Uganda have been put under quarantine after getting in ... ...

Brazzaville, Sep 23 Uganda has reported seven confirmed cases, including one death, amid the latest outbreak of the ... ...

Yangon, Sep 22 Myanmar has vaccinated more than 37 million people for Covid-19, data of the country's Ministry ... ...

Even as it faces the fury of large-scale floods, Pakistan is confronted by another severe challenge as malaria cases have begun to achieve unprecedented proportions with some suggesting that the country should look towards India for remedial measures ...

Juba, Sep 21 The South Sudanese government announced that it is stepping up vigilance along the borders following ... ...

New Delhi, Sep 18 Only 24 per cent of the eligible population has been covered so far (As ... ...

Madrid, Sep 9 Spain will start to administer the fourth dose of vaccine against Covid-19 on September 26, ... ...

Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers. ...